LEVOSALBUTAMOL 1.25mg. IP + IPRATROPIUM BROMIDE 500mcg. IP

A bronchodilator medication that makes breathing easier in chronic obstructive pulmonary disease individuals. Relaxes the airway smooth muscles and produces bronchodilation. A valuable approach for the maintenance and treatment of bronchospasm associated with chronic obstructive pulmonary disease, notably chronic bronchitis and emphysema. An effective bronchodilator drug for patients with acute asthma. (Faiqa Qureshi, 1998) Offers a statistically significant improvement in pulmonary function, as well as a reduction in the rate of hospitalizations. (G Rodrigo, 1999) Alleviates symptoms of chronic obstructive pulmonary disease, such as breathing difficulties, coughing, and wheezing. Effectively eases bronchospasms and enhances patency airways in the lungs. (Saab & Aboeed) Demonstrates a significantly greater improvement and longer duration of action than albuterol in patients with chronic obstructive airway disease. (S R Braun, 1989) A well-tolerated drug that provides significant bronchodilatory effect in subjects with mild persistent to moderate persistent asthma. (D A Handley, 2000) Produces significantly greater bronchodilation than racemic albuterol. (D’Alonzo, 2004) More effective medicine than albuterol in treating severely obstructed individuals and those not responding to metaproterenol. (S R Braun, 1989) A cost-effective alternative to racemic albuterol. (David M Schreck, 2005) Appears to be preferable to atropine in the treatment of obstructive airways disease. (Wanner, 1986)